Page 37 - Haematologica May 2022

Bone Marrow Transplantation
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors
Dietger Niederwieser,1,2,3 Helen Baldomero,4 Nosa Bazuaye,5,6
Caitrin Bupp,7 Naeem Chaudhri,8,9 Selim Corbacioglu,10,11 Alaa Elhaddad,5,12 Cristóbal Frutos,13,14 Sebastian Galeano,13,15 Nada Hamad,16,17 Amir Ali Hamidieh,8,18 Shahrukh Hashmi,19,20 Aloysius Ho,21,22 Mary M. Horowitz,23 Minako Iida,21,24 Gregorio Jaimovich,13,25 Amado Karduss,13,26
Yoshihisa Kodera,21,24 Nicolaus Kröger,10,27 Regis Peffault de Latour,10,28
Jong Wook Lee,21,29 Juliana Martínez-Rolón,13,30 Marcelo C. Pasquini,23
Jakob Passweg,10,31 Kristjan Paulson,32 Adriana Seber,13,33 John A. Snowden,10,34 Alok Srivastava,21,35 Jeff Szer,16,36 Daniel Weisdorf,7,37
Nina Worel,38 Mickey B. C. Koh,39,40 Mahmoud Aljurf,8,41 Hildegard Greinix,42 Yoshiko Atsuta21,43 and Wael Saber23 for the Worldwide Network of Blood and Marrow Transplantation WBMT
1University of Leipzig, Germany; 2Aichi Medical University School of Medicine, Nagakute, Japan; 3Lithuanian University of Health Sciences, Kaunas, Lithuania; 4The Worldwide Network of Blood and Marrow Transplantation (WBMT) Transplant Activity Survey Office, University Hospital, Basel, Switzerland; 5African Blood and Marrow Transplantation Group – AfBMT, Bern, Switzerland; 6University of Benin Teaching Hospital, Benin, Nigeria; 7CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN; USA; 8The Eastern Mediterranean Blood and Marrow Transplant Group (EMBMT), King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia; 9Oncology Center King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia; 10European Society for Blood and Marrow Transplantation (EBMT), Barcelona, Spain; 11Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Regensburg, Regensburg, Germany; 12Department of Pediatric Oncology and Stem Cell Transplantation Unit, Cairo University, Cairo, Egypt; 13Latin American Blood and Marrow Transplantation Group – LABMT, Bern, Switzerland; 14Cristóbal Frutos, Instituto de Previsión Social, Asunción, Paraguay; 15Sebastian Galeano, Hospital Británico, Montevideo, Uruguay; 16Australasian Bone Marrow Transplant Recipient Registry (ABMTRR), St. Vincent´s Hospital Sydney, Sydney, New South Wales, Australia; 17St. Vincent's Health Network, Kinghorn Cancer Center, Sydney, New South Wales, Australia; 18Pediatric Cell Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran; 19Sheikh Shakhbout Medical City, Abu Dhabi, UAE; 20MAYO Clinic, Rochester, MN, USA; 21The Asia Pacific Blood and Marrow Transplant Group (APBMT), Aichi Medical University School of Medicine, Nagakute, Japan; 22Singapore General Hospital Singapore, Singapore; 23CIBMTR, Medical College of Wisconsin, Milwaukee, WI, USA; 24Aichi Medical University School of Medicine, Deptartment of Promotion for Blood and Marrow Plantation, Nagakute, Japan; 25Fundación Favaloro, Sanatorio Anchorena, ITAC, Buenos Aires, Argentina; 26Instituto de Cancerología-Clínica Las Américas, Medellín, Colombia; 27Department of Stem Cell Transplantation, University Medical Center Hamburg, Hamburg, Germany; 28Saint-Louis Hospital, 1 avenue Claude Vellefaux, Paris, France; 29Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Republic of Korea; 30FUNDALEU, Buenos Aires, Argentina; 31Klinik für Hämatologie, Universitätsspital Basel, Basel, Switzerland; 32Cancercare Manitoba and the University of Manitoba and Cell Therapy Transplant Canada (CTTC), Winnipeg, Manitoba, Canada; 33Pediatric Department, Hospital Samaritano, Sao Paulo, Brazil; 34Department of Hematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; 35Christian Medical College, Vellore, India; 36Peter MacCallum Cancer Center and Royal Melbourne Hospital, Parkville, Vicoria, Australia; 37University of Minnesota, Minneapolis, MN, USA; 38Medical University of Vienna, Department of Blood Group Serology and Transfusion Medicine, Vienna, Austria; 39Infection and Immunity Clinical Academic Group St George’s Hospital and Medical School, London, UK; 40Academic Cell Therapy Facility and Programme Health Sciences Authority Singapore, Singapore; 41King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; 42Medical University of Graz, Division of Hematology, Graz, Austria and 43Japanese Data Center for Hematopoietic Cell Transplantation (JDCHCT),
Nagoya, Japan
Ferrata Storti Foundation
Haematologica 2022 Volume 107(5):1045-1053
Correspondence:
DIETGER NIEDERWIESER
dietger.niederwieser@medizin.uni-leipzig.de
Received: May 13, 2021. Accepted: July 21, 2021. Pre-published: August 12, 2021.
https://doi.org/10.3324/haematol.2021.279189 ©2022 Ferrata Storti Foundation
Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or inter- nal use. Sharing published material for non-commercial pur- poses is subject to the following conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for com- mercial purposes is not allowed without permission in writing from the publisher.
haematologica | 2022; 107(5)
1045
ARTICLE